NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Medical devices

81
Companies
with a public disclosure
31
Gave a number
a disclosed NPS
76
Median latest NPS
last 3 years
28
Silent
known companies, nothing published

Lighthouse companies

Owlet, Inc.
Medical devices · owletcare.com
OWLT12 NPS disclosures
77NPS · 2026
20212026
Retention 85% · 2025
“Owlet reported a Dream Sock Net Promoter Score of 77% and blended product NPS of 71% at the end of Q1.”
— reported by inkl.com · 14 May 2026
Latest: inkl.com
Lumexa Imaging
Medical devices · lumexaimaging.com
LMRI7 NPS disclosures
90NPS · 2026
20252026
“Lumexa Imaging reports Net Promoter Scores above 90 and record employee engagement.”
— reported by tipranks.com · 21 Aug 2026
Latest: tipranks.com
Thorne Healthtech, Inc.
Medical devices · thorne.com
8 NPS disclosures
69NPS · 2023
20212023
Retention 88% · 2023
“Our relentless focus on building a new model of health has resulted in a robust portfolio of science-driven products and high customer satisfaction, as demonstrated by ou…”
— Thorne Healthtech, Inc. · SEC 10-K annual report · filed 31 Mar 2023
Latest: SEC 10-K annual report
Longview Acquisition Corp.
Medical devices · butterflynetinc.com
BFLY7 NPS disclosures
64NPS · 2021
20202021
“Because our net promoter score is measured continuously it is subject to fluctuation; however, our net promoter score historically has remained strong. As of March 1, 202…”
— Longview Acquisition Corp. · SEC 10-K annual report · filed 12 May 2021
Latest: SEC 10-K annual report
Varian
Medical devices · varian.com
7 NPS disclosures
67NPS · 2019
20172019
“Integrations including integrated business processes for Taiwan and Poland complete. humediQ Global GmbH integration on track. Delight Customers Achieved three-point incr…”
— Varian · SEC proxy statement · filed 20 Dec 2019
Latest: SEC proxy statement
Better Therapeutics, Inc.
Medical devices · bettertherapeutics.io
6 NPS disclosures
61NPS · 2024
20222024
“Reduced weight % 1.3 • Improved 61 mood Mean A1C reduction for NPS Score at •”
— Better Therapeutics, Inc. · SEC 8-K filing · filed 11 Mar 2024
Latest: SEC 8-K filing
Outset Medical, Inc.
Medical devices · outsetmedical.com
OM
9NPS · 2024
Retention 90% · 2025Churn 10% · 2023
“On a scale from 1 indicating not likely to 10 indicating extremely likely to recommend Tablo, the study showed a mean Net Promoter Score of 9.2 at 6 months and 9.3 at 12 …”
— Leslie Trigg, Chair and Chief Executive Officer, Outset Medical, Inc. · Earnings call, Q3 2024 · 7 Nov 2024
Latest: Earnings call, Q3 2024
Philips Electronics
Medical devices · philips.com
PHG3 NPS disclosures
60NPS · 2022
20102022
“Our customers and quality KPIs have been improving in recent years. Our Net Promoter Score increased 8 percentage points to an average of over 60 in just the last few yea…”
— Frans van Houten, CEO, Philips Electronics · Earnings call, Q2 2022 · 25 Jul 2022
Latest: Earnings call, Q2 2022
PROCEPT BioRobotics Corp
Medical devices · procept-biorobotics.com
PRCT
92NPS · 2023
20232023
Retention 90% · 2024
“Another metric we track very closely is our Net Promoter Score, which measures customer experience and brand loyalty. As of December 2022, we surveyed our Net Promoter Sc…”
— Reza Zadno, Chief Executive Officer, PROCEPT BioRobotics Corp · Earnings call, Q4 2022 · 1 Mar 2023
Latest: SEC 8-K filing
HeraMED
Medical devices · heramed.com
60NPS · 2026
20262026
“HeraMED's HeraCARE Hybrid Maternity Care Solution achieved an NPS of 60 in its staged rollout with Lee Health System.”
— reported by smallcaps.com.au · 16 Sep 2026
Latest: smallcaps.com.au
OptimizeRx
Medical devices · optimizerx.com
OPRX
70NPS · 2023
NRR 90% · 2026Retention 100% · 2023
“FDB's OptimiseRx achieved £300 million in NHS savings and maintains a high Net Promoter Score of +70.”
— reported by digitalhealth.net · 20 Apr 2023
Latest: digitalhealth.net
Evolus
Medical devices · evolus.com
EOLS
70NPS · 2020
Retention 70% · 2019
“An NPS of 50 is excellent and anything over 70 is simply exceptional. Since we launched our app, our NPS score has ranged from the mid-60s to the high-80s with an average…”
— Mike Jafar, Chief Commercial Officer, Evolus · Earnings call, Q4 2019 · 25 Feb 2020
Latest: Earnings call, Q4 2019

More companies

Number of entries in brackets.

Silent

Companies we know of in medical devices that have published nothing on NPS or retention.

Fortune 500 #255
Fortune 500 #441
Fortune 500 #446
Life Sciences Equipment
Medical Devices
Medical Devices
Medical Device
Medical Devices
Medical Devices Manufacturer
Medical Devices
Medical Devices
Medical Device
Medical Devices
Medical Device Company
Medical Device Manufacturer
Medical Devices
Medical Device Maker
Dental Implants
Medical Devices
Medical Devices
Health Tech & AI
Medical Devices

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.